financetom
Business
financetom
/
Business
/
Adobe Investors Need 'Clearer Roadmap' to Dispel 'Apathy' on Shares, Morgan Stanley Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Adobe Investors Need 'Clearer Roadmap' to Dispel 'Apathy' on Shares, Morgan Stanley Says
Mar 13, 2025 8:32 AM

11:10 AM EDT, 03/13/2025 (MT Newswires) -- Adobe (ADBE) investors need a "clearer roadmap" to dispel "apathy" surrounding the stock even after the software company's Q1 results topped estimates by analysts, Morgan Stanley said Thursday in a report.

"Investors look for greater visibility on three key focal points to gain confidence in the forward trajectory" of the company, including detailed data on annual recurring revenue for digital media, cloud and document cloud segments, as well as artificial-intelligence products, the report said.

The new disclosure of generative artificial intelligence metrics "is a step in the right direction," the report said.

"Management acknowledged volatility in the broader macro environment, but highlighted expectations for Adobe to remain relatively durable," Morgan Stanley said.

An Adobe investor summit is scheduled for Tuesday.

Morgan Stanley cut its price target on Adobe stock to $600 from $660 and maintained its overweight rating. Several other analysts reduced price targets.

Shares of Adobe fell 12% in recent Thursday trading.

Price: 386.62, Change: -51.98, Percent Change: -11.85

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Kering delays full Valentino acquisition to 2028 amid debt concerns
Kering delays full Valentino acquisition to 2028 amid debt concerns
Sep 10, 2025
PARIS (Reuters) - Kering said on Wednesday that it will not fully buy Italian fashion brand Valentino until at least 2028, its first major move under new CEO Luca de Meo, pushing back the execution of an expensive deal that has been weighing on the heavily indebted group. The deal - announced just a day after de Meo was charged...
Swedish fintech Klarna shares open 30% above IPO price in NYSE debut
Swedish fintech Klarna shares open 30% above IPO price in NYSE debut
Sep 10, 2025
Sept 10 (Reuters) - Shares of Klarna ( KLAR ) opened 30% above their offer price in their New York Stock Exchange debut on Wednesday, giving the Swedish fintech a valuation of $19.65 billion. (Reporting by Arasu Kannagi Basil and Pritam Biswas in Bengaluru) ...
Prinses Máxima Center for Pediatric Oncology Implements Callisto™ from Volta Labs to Streamline Clinical Genomics Workflows
Prinses Máxima Center for Pediatric Oncology Implements Callisto™ from Volta Labs to Streamline Clinical Genomics Workflows
Sep 10, 2025
BOSTON, Sept. 10, 2025 /PRNewswire/ -- Volta Labs today announced that the Prinses Máxima Center for Pediatric Oncology has acquired the Callisto™ platform to streamline sample preparation across multiple genomics workflows, supporting both Illumina and Oxford Nanopore Technologies (ONT) sequencing platforms. The Prinses Máxima Center is the largest pediatric cancer center in Europe, dedicated to integrating care and research to...
US tariffs, pricing risks to be manageable for Big Pharma, Morningstar says
US tariffs, pricing risks to be manageable for Big Pharma, Morningstar says
Sep 10, 2025
(Reuters) -The impact of U.S. President Donald Trump's plan to levy import duties on pharmaceutical products and his push to lower drug prices are likely to be manageable for big U.S. and European drugmakers, according to an analysis by brokerage Morningstar. The report said the near term risk from the push to slash prescription drug prices to match those paid...
Copyright 2023-2026 - www.financetom.com All Rights Reserved